Korean J Pathol.  2010 Feb;44(1):42-47.

Expression of Cyclooxygenase-2 and Embryonic Lethal Abnormal Vision-Like Protein HuR in Gallbladder Carcinoma

Affiliations
  • 1Department of Pathology, Kyung Hee University College of Medicine, Seoul, Korea. kimyw@khu.ac.kr
  • 2Department of Pathology, Kyung Hee East-West Neo Medical Center, Seoul, Korea.

Abstract

BACKGROUND
Cyclooxygenase-2 (COX-2) is an enzyme that promotes proliferation of tumor cells. HuR is a member of the family of embryonic lethal abnormal vision-like proteins. Recent studies show that cytoplasmic HuR stabilizes the mRNA of COX-2 and regulates the expression of COX-2. Moreover, cytoplasmic HuR expression is associated with a poorer prognosis for patients with some cancers. The aim of this study was to investigate the expression patterns of and the relationship between COX-2 and HuR in gallbladder carcinoma.
METHODS
We analyzed COX-2 and HuR expression by immunohistochemical staining of 108 gallbladder carcinomas.
RESULTS
COX-2 expression and nuclear and cytoplasmic HuR expression were seen in, respectively, 61 (56.5%), 77 (71.3%), and 4 (3.7%) cases. COX-2 and nuclear HuR were simultaneously expressed in 44 of the 108 samples without any quantitative association between the levels of each. COX-2 expression correlated with tumor stage, differentiation (based on histology), lymph node metastasis, perineural invasion, and survival. Nuclear and cytological expression of HuR did not correlate with any clinical parameters.
CONCLUSIONS
COX-2 expression but not HuR may play an important role in the prognosis of patients with gallbladder carcinoma.

Keyword

Gallbladder neoplasms; Cyclooxygenase 2; ELAV-like protein 1

MeSH Terms

Cyclooxygenase 2
Cytoplasm
Gallbladder
Gallbladder Neoplasms
ELAV Proteins
ELAV-Like Protein 1
Humans
Lymph Nodes
Neoplasm Metastasis
Prognosis
Proteins
RNA, Messenger
Cyclooxygenase 2
Proteins
RNA, Messenger
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr